|Articles|November 1, 2011
- Pharmaceutical Executive-11-01-2011
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - November 2011
Red Light on the Access Autobahn
Advertisement
Articles in this issue
almost 14 years ago
Plant Managementalmost 14 years ago
The Road from No. 20almost 14 years ago
Five Yearsalmost 14 years ago
Spotlight on OTCsalmost 14 years ago
Invaralmost 14 years ago
Europe Tackles 'Advertising in Disguise' Fearsalmost 14 years ago
The Drug Shortages Strugglealmost 14 years ago
Euroservicealmost 14 years ago
Pharma's Visit to the Plastic Surgeonalmost 14 years ago
The Pharma Revolution RecalibratedNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Organon CEO Kevin Ali to Resign Following Internal Investigation into Nexplanon Sales
2
Novartis Enters $12 Billion Definitive Merger Agreement to Acquire Avidity Biosciences
3
GSK Agrees to $357 Million Exclusive License Agreement for Syndivia’s AntiBody-Drug Conjugate
4
ACS Calls Obesity a Condition That Must Be Treated with Medication and Surgery
5
